Litcius/Paper detail

Macrocyclic Peptides that Selectively Inhibit the <i>Mycobacterium tuberculosis</i> Proteasome

Hao Zhang, Hao-Chi Hsu, Shoshanna C. Kahne, Ryoma Hara, Wenhu Zhan, Xiuju Jiang, Kristin Burns-Huang, Tierra Ouellette, Toshihiro Imaeda, Rei Okamoto, Masanori Kawasaki, Mayako Michino, Tzu‐Tshin Wong, Akinori Toita, Takafumi Yukawa, Francesca Moraca, Jérémie Vendôme, Priya Saha, Kenjiro Sato, Kazuyoshi Aso, John D. Ginn, Peter T. Meinke, Michael A. Foley, Carl Nathan, K. Heran Darwin, Huilin Li, Gang Lin

2021Journal of Medicinal Chemistry17 citationsDOIOpen Access PDF

Abstract

dose dependently led to the accumulation of Pup-tagged GFP that is degradable but resistant to depupylation and death of nonreplicating Mtb under nitrosative stress. These results suggest that compounds of this class have the potential to develop as anti-TB therapeutics.

Topics & Concepts

Mycobacterium tuberculosisProteasomeChemistryTuberculosisMicrobiologyBiochemistryBiologyMedicinePathologyBiochemical and Molecular ResearchUbiquitin and proteasome pathwaysPeptidase Inhibition and Analysis